Naturalistic Study of Microdosing With Psilocybin

• Status: Completed
• Trial end date: 2021-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This study seeks to understand the neural, cognitive and behavioral effects of low doses of psilocybin administered in the form of dried mushroom material (0.5 g of Psilocybe cubensis) consumed in natural settings following a placebo-controlled double-blind experimental design.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: National Council of Scientific and Technical Research, Argentina
• Treatments: Psilocybin

Criteria

Inclusion Criteria:

1. Men and woman with more than 21 years.

2. Participans are planning to microdose using their own dried mushroom material and adhere to the experimental protocol.

3. No active psychiatric conditions requiring treatment with psychotropic medications.

4. Able to provide informed consent.

Excusion Criteria:

1. Use of psychotropic medication during the study, including stimulants such as caffeine.

2. Prior adverse reactions to psychedelics according to the Challenging Experiences Questionnaire administered during initial screening.

3. Pregnant women or women during lactation

4. History of high or low blood pressure or other cardiovascular risks.